U.S. Hospitality Stock News

Hasbro (NasdaqGS:HAS) plans to move its headquarters from Pawtucket, Rhode Island to Boston, Massachusetts by late 2026 and intends to sell its long held properties tied to the current site. The company is preparing new FIFA branded product lines ahead of the 2026 World Cup, targeting demand around the global tournament. Hasbro has also completed a sizeable debt offering, with proceeds that may be used to support its broader corporate plans. For you as an investor, these moves touch several...

U.S. Department of Energy approves expanded LNG export capacity at Cheniere Energy's Corpus Christi terminal. Authorization covers additional exports supported by new liquefaction trains at the Gulf Coast facility. Decision comes as global LNG markets face supply disruptions from Qatar and heightened demand volatility. For investors watching Cheniere Energy (NYSE:LNG), this approval directly relates to the company's core business of exporting liquefied natural gas from the U.S. Gulf Coast...

In recent months, CareTrust REIT reported strong year-over-year earnings per share growth and solid revenue gains, consistently topping analyst expectations and reinforcing its operational momentum. This run of earnings surprises, combined with analysts lifting future estimates and signs of institutional buying in the shares, has become a key driver of improving sentiment around the business. We’ll now examine how this sustained earnings momentum and analyst upgrades interact with CareTrust...

Thermo Fisher Scientific recently opened its Cryo-Electron Microscopy Drug Discovery Center in South San Francisco’s Oyster Point, giving pharmaceutical and biotechnology companies hands-on access to advanced cryo-EM technologies in a collaborative setting to accelerate structure-based drug discovery. By modeling the new U.S. center on a decade-long consortium in the U.K., Thermo Fisher is aiming to lower adoption barriers for cryo-EM and deepen its role in structure-guided therapeutics...

Drilling Tools International (DTI) just posted its FY 2025 third quarter numbers with revenue of US$38.8 million and a basic EPS loss of US$0.03, alongside a net loss of US$0.9 million, keeping the focus squarely on how quickly margins can tighten up from here. The company has seen quarterly revenue move in a tight band between US$37.5 million and US$42.9 million over the past six reported periods, while EPS has swung from a profit of US$0.03 per share to losses in the most recent quarters...

NANO Nuclear Energy (NasdaqCM:NNE) signed a memorandum of understanding with UAE based EHC Investment L.L.C. to deploy its KRONOS MMR Energy System in the Gulf region. The agreement targets potential projects in the UAE and other Gulf countries, including development of related nuclear fuel and supply chain capabilities. The MOU focuses on advancing micro modular reactor deployment for clean energy infrastructure across the region. NANO Nuclear Energy is a development stage company focused...

Freeport-McMoRan (NYSE:FCX) has signed a long term Memorandum of Understanding with the Indonesian government to extend operating rights at the Grasberg mine. The company plans a phased restart of the Grasberg Block Cave mine following recovery work after a significant mudslide. Freeport-McMoRan is advancing new projects and technology initiatives aimed at helping meet a global copper shortage linked to AI and green energy demand. Freeport-McMoRan enters this new phase at Grasberg with its...

Versant Media Group, Inc. recently reported full-year 2025 results showing lower sales of about US$6.69 billion and net income of US$930 million, while its board approved a US$0.375 quarterly dividend and authorized up to US$1 billion in share repurchases. Alongside these capital return moves, management is emphasizing disciplined bolt-on acquisitions, a shift toward digital and ad-supported platforms, and maintaining a strong balance sheet as a newly independent media company. Next, we’ll...

If you are looking at Helios Technologies and wondering whether the current share price still offers value, this article will walk you through what the numbers actually say. The stock last closed at US$65.00, with returns of 18.8% year to date and 76.8% over the past year. However, the recent 7 day and 30 day returns of 8.9% and 8.1% declines show that expectations and risk perceptions can shift quickly. Recent news has focused on Helios Technologies as a capital goods player listed on the...

Why Balchem is on investors’ radar today Balchem (BCPC) is back in focus after recent trading left the shares around $175.28, with year to date total return data and multi year performance figures giving investors fresh context for the current price. See our latest analysis for Balchem. Recent moves have been fairly mixed, with a 16.47% 90 day share price return and 13.80% year to date share price return contrasting with a relatively flat 0.38% 1 year total shareholder return. This suggests...

Chipotle Mexican Grill, NYSE:CMG, is under pressure as weakness across the restaurant industry aligns with rising concern about its slowing growth strategy. Recent commentary has highlighted a softer labor market and reduced restaurant spending as headwinds for Chipotle's customer traffic and sales. Investors are also focused on Chipotle's choice to avoid price promotions or value menus while competitors lean harder into discounting. For shareholders, the context around this news matters...

Syndax Pharmaceuticals (SNDX) is back in focus after reporting fourth quarter and full year 2025 results, highlighting sharp revenue growth tied to recently approved cancer therapies Revuforj and Niktimvo, as well as its expanding commercial footprint. See our latest analysis for Syndax Pharmaceuticals. The earnings release, third FDA approval within a year, conference appearance, and fresh shelf registration have all landed against a backdrop where the 1 year total shareholder return of...

Trevi Therapeutics recently announced that its senior management took part in several March 2026 healthcare conferences to present data on Haduvio, an oral nalbuphine ER therapy in development for chronic cough associated with idiopathic pulmonary fibrosis and refractory chronic cough. The company highlighted that Haduvio is the first investigational therapy reported to deliver a statistically significant reduction in cough frequency across both of these hard‑to‑treat patient groups, in an...

Genius Sports (NYSE:GENI) announced a definitive agreement to acquire Legend, expanding its live sports data and ad tech capabilities. The company reported revenue and EBITDA figures for 2025 alongside the Legend deal, highlighting a shift in its data monetization strategy. Genius Sports also unveiled new partnerships, including a direct integration with Magnite for real time ad activation. An expanded collaboration with NBC Sports Regional Networks will use AI driven tools for augmented...

If you are wondering whether Elastic's share price reflects its true worth, you are not alone. Many investors are asking if the current level offers value or just more volatility. Over the short term the stock has moved around, with a 3.2% gain over 7 days sitting against a 11.0% decline over 30 days and a 26.0% decline year to date, while the 1 year return sits at a 43.4% decline and the 5 year return at a 53.8% decline. These moves have kept attention on Elastic as investors weigh its long...

Universal Display (NasdaqGS:OLED) has extended its long term OLED material supply and license agreements with LG Display. The renewal covers multiple years, reinforcing an existing relationship between the two companies. Universal Display focuses on phosphorescent OLED materials and related intellectual property, which are used in a wide range of display applications. LG Display is one of the major global OLED panel producers, so these renewed agreements connect a key material supplier with...

Nike recently announced a major restructuring that includes about 775 job cuts at U.S. distribution centers and an expected US$300 million pretax severance charge, as part of efforts to streamline operations and improve efficiency under CEO Elliott Hill. This reset, which also raises questions about the future of lagging subsidiary Converse, signals how aggressively Nike is trying to protect margins and refocus on higher-performing parts of the business. We’ll now examine how this US$300...

If you are trying to figure out whether Immunome’s share price reflects its real worth, you are not alone. This article is built to help you weigh what the current market price might actually represent. Over the short term, the stock has had mixed returns, with a 3.8% decline over the last 7 days and a 20.3% decline over the last 30 days, even though the 1 year return sits at 125.3% and the 3 year return is very large at about 4x, compared to a 27.9% decline over 5 years and a modest 1.1%...

ConnectOne Bancorp (CNOB) is drawing investor attention after recent share price pressure, with the stock down about 1.5% on the day and showing declines over the past week and month. See our latest analysis for ConnectOne Bancorp. Zooming out, the recent 1-month share price return of a 7.84% decline and softer short-term momentum contrast with a 1-year total shareholder return of 10.05%. This suggests longer-term holders have still seen gains. If this pullback has you thinking about where...

Imperial Petroleum (IMPP) has put up another solid set of numbers, with Q3 FY 2025 revenue of about US$41.4 million and basic EPS of US$0.30, alongside trailing 12 month revenue of roughly US$136.1 million and EPS of US$1.09 that frame the current run rate. The company has seen quarterly revenue move from US$26.2 million in Q4 FY 2024 through US$32.1 million and US$36.3 million in the first two quarters of FY 2025 to US$41.4 million in Q3, while basic EPS over the same stretch has ranged...

If you are wondering whether nLIGHT's current share price lines up with the underlying business, you are not alone. This article is built to help you frame that question clearly. nLIGHT's share price closed at US$58.64, with returns of 4.4% over 7 days, 33.7% over 30 days, 52.8% year to date, and a very large 1 year return that signals a major shift in how the market is pricing the stock. Recent news around nLIGHT has focused on its position in the technology sector and how investors are...

NXP Semiconductors recently reported Q4 2025 results that beat analyst expectations on revenue and earnings, but issued Q1 2026 guidance calling for sequential revenue and margin pressure after a year marked by a 3% revenue decline and weakness in its Communications Infrastructure segment. Despite this softer near-term outlook and a deterioration in GAAP profitability, analysts continue to rate the company positively, highlighting its diversified growth drivers across automotive, industrial...

Earnings recap and context Caribou Biosciences (CRBU) has just posted another quarterly loss, with Q3 FY 2025 revenue of about US$2.2 million and basic EPS of US$0.30 in the red, underscoring that the company is still firmly in investment mode. Over recent periods, revenue has moved in a tight band between roughly US$2.0 million and US$3.5 million per quarter, while quarterly basic EPS has ranged from a loss of US$0.30 to US$0.58. This gives investors a clear view of a business that is still...

Hamilton Lane (NasdaqGS:HLNE) has entered a long term partnership with Guardian to manage a $5b private equity portfolio. The agreement includes ongoing annual commitments from Guardian for at least ten years. The mandate increases Hamilton Lane's assets under management and supports visibility into future fee related earnings. Hamilton Lane focuses on private markets investment solutions, so a $5b mandate from a large institutional client directly relates to its core business. For...